ANNEX 3 Linies.pdf - FundaciÃ³ Institut d'InvestigaciÃ³ en CiÃ¨ncies de ...

More documents

Recommendations

Info

IF: 4,802 Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Ledergerber B, Lundgren JD; EuroSIDA Study Group. Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression. JAIDS-J ACQ IMM DEF 2009 Apr 15;50(5):457-63. IF: 4,207 Prado, JG; Honeyborne, I; Brierley, I; Puertas, MC; Martinez-Picado, J; Goulder, PJR Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8(+) T-Cell Epitope in p1 Gag Protein J VIROL 2009-JAN 15; 83 (2): 1018-1025 IF: 5,150 Pruvost, A; Negredo, E; Theodoro, F; Puig, J; Levi, M; Ayen, R; Grassi, J; Clotet, B Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir ANTIMICROB AGENTS CH 2009-MAY 1; 53 (5): 1937-1943 IF: 4,802 Puertas, MC; Buzon, MJ; Artese, A; Alcaro, S; Menendez-Arias, L; Perno, CF; Clotet, B; Ceccherini-Silberstein, F; Martinez- Picado, J Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility J VIROL 2009 AUG 1;83:7434-7439 IF: 5,150 Puigdomenech, I; Massanella, M; Cabrera, C; Clotet, B; Blanco, J On the steps of cell-to-cell HIV transmission between CD4 T cells RETROVIROLOGY 2009; 6:89 IF: 4,105 Radi M, Maga G, Alongi M, Angeli L, Samuele A, Zanoli S, Belluci L, Tafi A, Casaluce G, Giorgi G, Armand-Ugon M, Gonzalez E, Esté JA, Baltzinger M, Bec G, Dumas P, Ennifar E, Botta M Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (S-DABO) Derivatives as Potent HIV-1 Reverse Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants J MED CHEM 2009; 52, 840-851 IF: 4,802 Ramsay AJ, Quesada V, Sanchez M, Garabaya C, Sardà MP, Baiget M, Remacha A, Velasco G, López-Otín C. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. HUM MOL GENET 2009 Oct 1;18(19):3673-83. Epub 2009 Jul 10. IF: 7,386 Rousseau, CM; Lockhart, DW; Listgarten, J; Maley, SN; Kadie, C; Learn, GH; Nickle, DC; Heckerman, DE; Deng, W; Brander, C; Ndung'u, T; Coovadia, H; Goulder, PJR; Korber, BT; Walker, BD; Mullins, JI Rare HLA Drive Additional HIV Evolution Compared to More Frequent Alleles AIDS RES HUM RETROV 2009; 25:297-303 IF: 2,178 Rusconi S, Lo Cicero M, Viganò O, Sirianni F, Bulgheroni E, Ferramosca S, Bencini A, Bianchi A, Ruiz L, Cabrera C, Martinez-Picado J, Supuran CT, Galli M. New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses. Molecules 2009 May 22;14(5):1927-37 IF: 2,359 Russell, DG; Cardona, PJ; Kim, MJ; Allain, S; Altare, F Foamy macrophages and the progression of the human tuberculosis granuloma NAT IMMUNOL 2009; 10:943-948 IF: 26,000 Pàgina 8 de 67
Sabariegos R, Picazo F, Domingo B, Franco S, Martinez MA, Llopis J. Fluorescence resonance energy transfer-based assay for characterization of hepatitis C virus NS3-4A protease activity in live cells. ANTIMICROB AGENTS CH 2009 Feb;53(2):728-34. Epub 2008 Dec 8. IF: 4,802 Tsibris AM, Korber B, Arnaout R, Russ C, Lo CC, Leitner T, Gaschen B, Theiler J, Paredes R, Su Z, Hughes MD, Gulick RM, Greaves W, Coakley E, Flexner C, Nusbaum C, Kuritzkes DR. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLOS ONE 2009 May 25;4(5):e5683. IF: 4,351 Valles, X; Sarrias, MR; Casals, F; Farnos, M; Piner, R; Suarez, B; Morais, L; Mandomando, I; Sigauque, B; Roca, A; Alonso, PL; Torres, A; Thielens, NM; Lozano, F Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children TISSUE ANTIGENS 2009; 74:298-307 IF: 2,330 Vera, J; Fenutria, R; Canadas, O; Figueras, M; Mota, R; Sarrias, MR; Williams, DL; Casals, C; Yelamos, J; Lozano, F The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome P NATL ACAD SCI USA 2009; 106:1506-1511 IF: 9,432 Walter M, Philotheou A, Bonnici F, Ziegler AG, Jimenez R, on behalf of the NBI-6024 Study Group (Eva Aguilera). No effect of the altered peptide ligand NBI-6024 on β-cell residual function and insulin needs in new-onset type 1 diabetes. DIABETES CARE 2009, 32: 2036-2040 IF: 6,718 INVESTIGACIÓ CLÍNICA Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, Lees KR, Toni D; SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). STROKE 2009 Jul;40(7):2442-9. Epub 2009 May 21. IF: 7,041 Andres, A; Marcen, R; Valdes, F; Plumed, J; Sola, R; Errasti, P; Lauzurica, R; Pallardo, L; Bustamante, J; Amenabar, JJ; Plaza, JJ; Gomez, E; Grinyo, JM; Rengel, M; Puig, JM; Sanz, A; Asensio, C; Andres, I A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function. CLIN TRANSPLANT 2009-JAN-FEB; 23 (1): 23-32 IF: 2,004 Antonio J. Blasco AJ, Ferrándiz C, García A, Lázaro P, Liso J Eficiencia de los agentes biológicos en el tratamiento de la psoriaris moderada-grave. Actas Dermosifiliogr 2009;100:792-803 (A) Arenillas JF, Sandoval P, Pérez de la Ossa N, Millán M, Guerrero C, Escudero D, Dorado L, López-Cancio E, Castillo J, Dávalos A. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men. STROKE 2009 ;40(2):344-349. Epub 2008 Dec 24 IF: 7,041 Bassas-Vila J Patrones histológicos de los procesos inflamatorios de la piel PIEL 2009;24:380-386 (A) Benvenuti F, Carrascosa JM, Boada A, Ferrandiz C. Disseminated Strongyloides stercoralis infection presenting with cutaneous manifestations in an immunosuppressed patient EUR J DERMATOL 200;19(4):404-5.(A) Pàgina 9 de 67
Page 1 and 2: ANNEX 3 Relació detallada de la pr
Page 3 and 4: Pàgina 3 de 67
Page 5 and 6: Evolution of foamy macrophages in t
Page 7: J NUTR 2009-MAR; 139 (3): 603-610 I
Page 11 and 12: Carrascosa JM, Ferránidz C Tratami
Page 13 and 14: García-Casares E, Mateo L, García
Page 15 and 16: M Batlle, Quesada MD, Moreno M, JM
Page 17 and 18: ENFERM INFEC MICR CL 2009 Jan;27(1)
Page 19 and 20: Gonvers JJ, Froehlich F, Vader JP;
Page 21 and 22: JAIDS-J ACQ IMM DEF 2009 DEC 1;52:4
Page 23 and 24: J VIRAL HEPATITIS 2009; 16:513-518
Page 25 and 26: TOLERVIP-MS: inducció de tolerànc
Page 27 and 28: Caracterización y efectos de la in
Page 29 and 30: DOMINGUEZ BENITEZ, JOSE ANTONIO - M
Page 31 and 32: CÀNCER Publicacions INVESTIGACIÓ
Page 33 and 34: Alvarez, M; Lezcano, C; Ponton, JL;
Page 35 and 36: R Parody, J Pérez de Oteyza, E Bur
Page 37 and 38: subgroup of symptomatic multiple my
Page 39 and 40: IF: 5,673 Barba, I; Sanz, C; Barber
Page 41 and 42: Bio-ANITA project: increased BRCA1
Page 43 and 44: EPIDEMIOLOGIA CLÍNICA Y MOLECULAR
Page 45 and 46: HEPATOLOGY 2009, 50(supll):A875 IF:
Page 47 and 48: Vallès X, Murga GB, Hernández G,
Page 49 and 50: 2010). Durada: 3 anys - (2007-2010)
Page 51 and 52: H; Lehto, VP; Lundin, J A European
Page 53 and 54: IF: 1,694 Hernandez-Sabate, A; Gil,
Page 55 and 56: IF: 1,231 Ardèvol M, Valera M, Hid
Page 57 and 58: Cardona G, Bosch M, Costa J, Planas
Page 59 and 60:
Garcia-Pagan, JC; Villanueva, C; Al
Page 61 and 62:
Arch Soc Esp Oftalmol 2009 Mar;84(3
Page 63 and 64:
Differences in Health Care of HIV-i
Page 65 and 66:
INVESTIGACIÓ TRASLACIONAL Alvarez,
Page 67:
(nadolol o carvedilol según respue
show all

ANNEX 3 Linies.pdf - FundaciÃ³ Institut d'InvestigaciÃ³ en CiÃ¨ncies de ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?